300 related articles for article (PubMed ID: 22382634)
1. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands.
Shiotani A; Uedo N; Iishi H; Murao T; Kanzaki T; Kimura Y; Kamada T; Kusunoki H; Inoue K; Haruma K
J Gastroenterol; 2012 Sep; 47(9):988-98. PubMed ID: 22382634
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
Shiotani A; Uedo N; Iishi H; Tatsuta M; Ishiguro S; Nakae Y; Kamada T; Haruma K; Merchant JL
Int J Cancer; 2007 Sep; 121(6):1182-9. PubMed ID: 17520681
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer.
Shiotani A; Murao T; Kimura Y; Matsumoto H; Kamada T; Kusunoki H; Inoue K; Uedo N; Iishi H; Haruma K
Br J Cancer; 2013 Oct; 109(9):2323-30. PubMed ID: 24104965
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.
Shiotani A; Nishi R; Uedo N; Iishi H; Tsutsui H; Ishii M; Imamura H; Kamada T; Hata J; Haruma K
Digestion; 2010; 81(4):223-30. PubMed ID: 20110706
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.
Shin SH; Jung DH; Kim JH; Chung HS; Park JC; Shin SK; Lee SK; Lee YC
PLoS One; 2015; 10(11):e0143257. PubMed ID: 26580072
[TBL] [Abstract][Full Text] [Related]
6. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
Chan AO; Peng JZ; Lam SK; Lai KC; Yuen MF; Cheung HK; Kwong YL; Rashid A; Chan CK; Wong BC
Gut; 2006 Apr; 55(4):463-8. PubMed ID: 16428266
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin use.
Watari J; Ito C; Shimoda T; Tomita T; Oshima T; Fukui H; Das KM; Miwa H
Sci Rep; 2019 Aug; 9(1):12559. PubMed ID: 31467363
[TBL] [Abstract][Full Text] [Related]
8. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF
Cancer Lett; 2014 Dec; 355(1):106-12. PubMed ID: 25218349
[TBL] [Abstract][Full Text] [Related]
9. Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication.
Okubo M; Tahara T; Shibata T; Nakamura M; Yoshioka D; Maeda Y; Yonemura J; Ishizuka T; Arisawa T; Hirata I
J Gastroenterol; 2011 Feb; 46(2):175-82. PubMed ID: 20967557
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs.
Vasapolli R; Venerito M; Schirrmeister W; Thon C; Weigt J; Wex T; Malfertheiner P; Link A
PLoS One; 2021; 16(4):e0249282. PubMed ID: 33857171
[TBL] [Abstract][Full Text] [Related]
11. Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis.
Fassan M; Saraggi D; Balsamo L; Cascione L; Castoro C; Coati I; De Bernard M; Farinati F; Guzzardo V; Valeri N; Zambon CF; Rugge M
Oncotarget; 2016 Jan; 7(4):4915-24. PubMed ID: 26701848
[TBL] [Abstract][Full Text] [Related]
12. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
[TBL] [Abstract][Full Text] [Related]
13. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and predictors of gastric cancer after
Shichijo S; Hirata Y
World J Gastroenterol; 2018 May; 24(20):2163-2172. PubMed ID: 29853734
[No Abstract] [Full Text] [Related]
16. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.
Kodama M; Murakami K; Okimoto T; Abe H; Sato R; Ogawa R; Mizukami K; Shiota S; Nakagawa Y; Soma W; Arita T; Fujioka T
Scand J Gastroenterol; 2013 Nov; 48(11):1249-56. PubMed ID: 24079881
[TBL] [Abstract][Full Text] [Related]
17. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
[TBL] [Abstract][Full Text] [Related]
19. Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.
Hwang JJ; Lee DH; Kang KK; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(13):3936-43. PubMed ID: 25852279
[TBL] [Abstract][Full Text] [Related]
20. Association between
Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]